About Kumar Brothers Pharma Private Limited
Data last updated:
Kumar Brothers Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC151712. Its GSTIN is 27AACCK5488R1ZL (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Surendra Bhabutmal Jain (Managing Director) and Kumarpal Bhabutmal Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹34.94 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹10.81 Lakh (net margin 0.3%) and EBITDA of ₹75.56 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 12% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.21 Cr and satisfied charges of ₹3 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kbppl.net.
Company details
Contact details
Kumar Brothers Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is kbppl.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA1 Unit No 204 2nd Floor Centre Point Condominium 243A N.M.Joshimarg Bawlamasjid Delisle L, Ower Parel, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Kumar Brothers Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kumar Brothers Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kumar Brothers Pharma Private Limited, buy the company report.
Financials of Kumar Brothers Pharma Private Limited
FY 2025 filings availableKumar Brothers Pharma Private Limited reported revenue of ₹34.94 Cr (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 6% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kumar Brothers Pharma Private Limited, buy the company report.
Board of directors of Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumarpal Bhabutmal Jain Also directs: Kolor Bio - Genetics Private Limited | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
| Kunal Kumarpal Jain Also directs: Kolor Bio - Genetics Private Limited | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
| Surendra Bhabutmal Jain | Managing Director | 02 Mar 2005 | 21 Years 7 Months | Current |
| Bhavesh Surendra Jain | Director | 02 Mar 2005 | 21 Years 7 Months | Current |
Peer comparison
Kumar Brothers Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emjay Capfin Private Limited | ₹35.07 Cr (FY 2025) | -4.0% | Guwahati, Assam, India | |||
| Elixir Life Care Private Limited | ₹35.03 Cr (FY 2025) | -1.0% | Chennai, Tamil Nadu, India | |||
| Kumar Brothers Pharma Private Limitedthis company | ₹34.94 Cr (FY 2024) | ₹10.81 Lakh | 0.3% | 6.0% | 25 | Mumbai, Maharashtra, India |
| Raghavam Logistics Private Limited | ₹34.67 Cr (FY 2025) | -7.0% | Raipur, Chhattisgarh, India | |||
| Medsol India Overseas Private Limited | ₹34.67 Cr (FY 2025) | 17.0% | Noida, Uttar Pradesh, India | |||
| Aril Bioscience Private Limited | ₹34.52 Cr (FY 2025) | 36.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Kumar Brothers Pharma Private Limited, buy the company report.
Auditor
Kumar Brothers Pharma Private Limited is audited by SURESH TARACHAND RATHOD for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURESH TARACHAND RATHOD | FY 2023 | 042622 |
Shareholding
The shareholding of Kumar Brothers Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kumar Brothers Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Apr 2015 | 10567144 | Hdfc Bank Limited | ₹1.5 Cr | Open | |
| 05 Sep 2006 | 10022101 | Hdfc Bank Limited | ₹1.25 Cr | Open | |
| 25 Oct 2005 | 90349383 | The United Western Bank Ltd. | ₹36 Lakh | Open | |
| 26 Mar 1976 | 90374657 | Central Bank of India | ₹10 Lakh | Open | |
| 21 Aug 2007 | 10066713 | Union Bank of India | ₹3 Cr | Satisfied |
To see the full charge records of Kumar Brothers Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Kumar Brothers Pharma Private Limited has 3 court cases on record: 3 filed by Kumar Brothers Pharma. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Insolvency matter | Filed by the company against Vascular Therapeutics India Pvt. Ltd and 2 others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed by the company against Vascular Therapeutics India Pvt. Ltd. | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed by the company against Vascular Therapeutics India Pvt. Ltd | Disposed |
To see the full case history of Kumar Brothers Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kumar Brothers Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kumar Brothers Pharma Private Limited has a workforce of 25 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Kumar Brothers Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCK5488R1ZL | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kumar Brothers Pharma Private Limited, buy the company report.
Recent activity
Kumar Brothers Pharma Private Limited has 10 board changes on record since 2005: 7 appointments and 3 cessations. The latest: Kirtesh Surendra Jain ceased to be Director on 11 Feb 2022.
8 earlier events are in the company report.
Frequently asked questions
Kumar Brothers Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 March 2005 (21+ years old) and is registered under CIN U24230MH2005PTC151712.
Kumar Brothers Pharma has 4 current directors:
- Surendra Bhabutmal Jain - Managing Director
- Kumarpal Bhabutmal Jain - Director
- Kunal Kumarpal Jain - Director
- Bhavesh Surendra Jain - Director
The latest financial statements of Kumar Brothers Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kumar Brothers Pharma is 27AACCK5488R1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kumar Brothers Pharma is U24230MH2005PTC151712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kumar Brothers Pharma has 3 court cases on record: 3 filed by the company. Most are in the nclt.
Kumar Brothers Pharma was incorporated on 02 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kumar Brothers Pharma by revenue are Emjay Capfin Private Limited, Elixir Life Care Private Limited, Raghavam Logistics Private Limited, Medsol India Overseas Private Limited, Aril Bioscience Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kirtesh Surendra Jain ceased to be Director on 11 Feb 2022. Kumarpal Bhabutmal Jain was appointed as Director on 03 Dec 2018. Kunal Kumarpal Jain was appointed as Director on 03 Dec 2018. Kumar Brothers Pharma has 10 board changes on record in total.
Kumar Brothers Pharma can be reached through the website kbppl.net. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Kumar Brothers Pharma is at A1 Unit No 204 2nd Floor Centre Point Condominium 243A N.M.Joshimarg Bawlamasjid Delisle L, Ower Parel, Mumbai, Maharashtra, India – 400013.